UNRESECTABLE BLADDER UROTHELIAL CARCINOMA
Clinical trials for UNRESECTABLE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy trial offers hope for Tough-to-Treat bladder cancer
Disease control OngoingThis study is testing whether adding a chemotherapy drug (eribulin) to an immunotherapy drug (atezolizumab) works better than the immunotherapy drug alone for people with advanced bladder cancer that has spread or come back. It is for patients who cannot take a standard chemother…
Matched conditions: UNRESECTABLE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Personalized cancer fight: matching drugs to your Tumor's genetic fingerprint
Disease control OngoingThis study is testing whether specific genetic markers in a patient's tumor can predict if they will respond well to immunotherapy drugs. It is for people with advanced bladder cancer that has spread and has stopped responding to standard chemotherapy. Participants receive two im…
Matched conditions: UNRESECTABLE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC